Debridement — the removal of callus, necrotic tissue, slough, and non-viable wound edge from a diabetic foot ulcer — is one of the oldest interventions in wound care and remains one of the few that appears in every major evidence-based guideline. It is also one of the least glamorous. Advanced dressings, biologics, and oxygen therapies attract most of the research attention, yet a 2023 review in JAMA listed surgical debridement, pressure offloading, and treatment of ischaemia and infection as the first-line therapies for diabetic foot ulceration, with adjunctive technologies layered on top of that foundation rather than substituting for it (Armstrong et al., 2023). Understanding why debridement matters, and which techniques the evidence supports, clarifies a great deal about how chronic foot wounds are managed.
Why Chronic Wounds Need Wound Bed Preparation
A diabetic foot ulcer that has stalled is biologically different from an acute wound. The wound bed accumulates devitalised tissue, senescent cells, excess proteases, and bacterial biofilm — a polymicrobial community embedded in a protective matrix that resists both host immunity and topical antimicrobials. Surrounding hyperkeratotic callus adds a further problem: it concentrates mechanical pressure over the ulcer with every step.
Debridement addresses all of these at once. Removing necrotic tissue and callus lowers local pressure, reduces bacterial burden, allows accurate assessment of true wound depth, and converts a chronic wound environment toward an acute healing phenotype. The 2023 International Working Group on the Diabetic Foot (IWGDF) guideline on wound healing interventions frames debridement and wound bed preparation as principles “of utmost importance” when attempting to heal a chronic diabetes-related foot ulcer, and positions every adjunctive therapy as something to consider only when best standard of care has failed to heal the wound on its own (Chen et al., 2023).
Sharp Debridement as the Reference Standard
Sharp (or conservative sharp) debridement — performed with scalpel, curette, or tissue nippers — is the technique most consistently recommended. The IWGDF 2023 guideline recommends sharp debridement together with basic dressings that absorb exudate and maintain a moist wound environment, and explicitly advises against substituting autolytic, biosurgical, hydrosurgical, chemical, laser, or ultrasonic debridement for standard care. Enzymatic debridement is not recommended routinely, though the guideline allows that it may be considered where access to sharp debridement is limited by resources or by the absence of appropriately skilled clinicians (Chen et al., 2023).
That last caveat reflects a practical reality documented in Australian survey work: sharp debridement was the predominant method used, performed at every visit by 84% of responding podiatrists, but frequency was determined not only by clinical indications — callus, slough, and infection ranked as the top three determinants — but also by staffing resources. Podiatrists in regional and remote settings debrided considerably less often than metropolitan colleagues (Nube et al., 2021). Access, not evidence, is often the limiting factor.
What the Comparative Evidence Actually Shows
The comparative literature is thinner than the strength of guideline language might suggest. A systematic review and meta-analysis of 11 randomised controlled trials and three non-randomised studies covering 800 patients found that autolytic debridement significantly increased healing rates (relative risk 1.89; 95% CI 1.35–2.64) and that larval (maggot) debridement reduced amputation (RR 0.43; 95% CI 0.21–0.88) without increasing complete healing. Surgical debridement was associated with shorter healing time than conventional wound care in a single trial. The authors concluded that evidence directly comparing methods was of low quality, and that technique selection should therefore rest on available expertise, patient preference, clinical context, and cost (Elraiyah et al., 2016).
Ultrasound-assisted debridement has been examined separately. A meta-analysis of eight randomised trials involving 263 participants found a pooled odds ratio for healing of 2.22 (95% CI 0.96–5.11) favouring ultrasound-assisted debridement, and greater mean wound area reduction (74.6% versus 56.9%), but neither difference reached statistical significance and healing times were comparable between groups (Flores-Escobar et al., 2022). There is also an occupational consideration: low-frequency contact ultrasonic debridement generates aerosol, and measured environmental contamination was significantly higher when suction attachment was not used, prompting recommendations for suction and appropriate personal protective equipment during these procedures (Álvaro-Afonso et al., 2023).
Clinical Summary
Debridement remains a cornerstone of diabetic foot ulcer care because it simultaneously reduces mechanical load, disrupts biofilm, removes non-viable tissue, and permits accurate wound assessment. Current guideline consensus favours sharp debridement as the standard technique, with alternative modalities reserved for circumstances where sharp debridement is impractical. The comparative evidence between methods remains of low certainty, so decisions are appropriately individualised — accounting for wound characteristics, perfusion status, pain, patient preference, and clinician skill. Notably, debridement is not a stand-alone treatment: its benefit is realised only alongside offloading, management of infection, and correction of ischaemia, which is why multidisciplinary care is associated with lower major amputation rates than usual care.
References
- Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic Foot Ulcers: A Review. JAMA. 2023;330(1):62–75.
- Chen P, Vilorio NC, Dhatariya K, et al. Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2023/2024;40(3):e3644.
- Elraiyah T, Domecq JP, Prutsky G, et al. A systematic review and meta-analysis of débridement methods for chronic diabetic foot ulcers. Journal of Vascular Surgery. 2016;63(2 Suppl):37S–45S.
- Nube VL, Alison JA, Twigg SM. Frequency of sharp wound debridement in the management of diabetes-related foot ulcers: exploring current practice. Journal of Foot and Ankle Research. 2021;14(1):52.
- Flores-Escobar S, Álvaro-Afonso FJ, García-Álvarez Y, et al. Ultrasound-Assisted Wound (UAW) Debridement in the Treatment of Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2022;11(7):1911.
- Álvaro-Afonso FJ, Flores-Escobar S, Sevillano-Fernández D, et al. A deeper look at low-frequency contact ultrasonic debridement in the clinical management of patients with diabetic foot ulcers. Wound Repair and Regeneration. 2023;31(6):745–751.
Comments
